Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Rimactazid 150/75 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Rimactazid 150/75

Approved

STANDARD

Rimactazid 150/75

Panacea Biotec Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 70078a6f1e679038
Company: Panacea Biotec Limited
Type: Standard

Approval Details

Approval Id: 70078a6f1e679038
Drug Approval Philippines Name: Rimactazid 150/75
Product Name: Rimactazid 150/75
Registration Number: DRP-13614
Brand Name: Rimactazid 150/75
Generic Name: Rifampicin + Isoniazid
Dosage Form: Film-Coated Tablet
Dosage Strength: 150 mg/75 mg
Manufacturer: Panacea Biotec Limited
Importer: Sandoz Philippines Corporation
Distributor: Sandoz Philippines Corporation
Company Detail Path: /organization/panacea-biotec-limited
Issuance Date: 17 March 2023
Expiry Date: 17 March 2028
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

70078a6f1e679038

Type

Standard

Back to Philippines FDA Approvals